£20.0M
The oversubscribed round included backing from Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence.
E
Evonetix
Evonetix builds semiconductor technology platforms for desktop DNA synthesis.
£20.0MTotal raised
Evonetix develops semiconductor technology applied to DNA synthesis, offering a benchtop platform for accurate gene assembly. The firm uses a silicon chip to control synthesis across thousands of reaction sites.
Categories
Team
Colin McCracken
Chief Executive Officer
Colin brings executive experience from leadership roles at Evonetix, Fluidigm Corporation, and Thermo Fisher Scientific. He currently serves as senior vice president and chief commercial officer at Leica Biosystems.
LinkedIn
Paul Beastall
Chair of the Board of Directors
Paul chairs the board of directors at Evonetix and previously served as chief executive officer at HutanBio. He brings governance and advisory experience across life sciences, biology, and early stage organisations.
LinkedIn